For 37 years, Novo Nordisk Pharmatech was an independent company known as FeF Chemicals. The business was acquired by Novo Nordisk in 1986 and over the years that followed FeF Chemicals quickly evolved into a pharmaceutical specialist.
Management decided that the business would have further potential under the strength of the Novo Nordisk group name. As a result, a major rebranding project was initiated with CBC to develop a new identity and creative platform for internal and external channels.
Rasmus Hother le Fevre
Managing Director, Novo Nordisk Pharmatech